Press Releases Destiny Pharma plc

Equities

Market Closed - London S.E. Other stock markets 11:35:20 2024-07-05 EDT			5-day change	1st Jan Change
8.5 ^GBX	0.00%		-2.86%	-87.86%

06-18	Destiny Pharma presents "exciting" data for ringworm drug	AN
06-12	EARNINGS AND TRADING: Intuitive Investments NAV rises, talks up Hui10	AN

Destiny Pharma : Result of 2024 Annual General Meeting	06-13	PU
Destiny Pharma : Notice of 2024 Annual General Meeting	05-09	PU
Destiny Pharma : Interim results for the six months ended 30 June 2023	23-09-20	PU
Destiny Pharma : Business Update	23-06-29	PU
Destiny Pharma's nasal spray project already delivering "more than hoped for"	23-05-02	AQ
Destiny Pharma says XF-73 now "very well positioned" for a partnering programme	23-04-18	AQ
Destiny Pharma upbeat on prospects for C. Difficile treatment	23-04-06	AQ
Destiny Pharma looking to move on to phase III with XF-73 nasal gel	23-03-27	AQ
Destiny Pharma "making real progress"	23-03-08	AQ
Destiny Pharma : Director Disclosure	22-12-02	PU
Destiny Pharma PLC 'leads the world' in new approach to preventing hospital infections	22-11-21	AQ
Destiny Pharma PLC 'leads the world' in new approach to preventing hospital infections	22-11-21	EQ
Destiny Pharma : Chair’s Investor Update	22-07-28	PU
Destiny Pharma : 26 July – Publication of new data on NTCD-M3	22-07-26	PU
Destiny Pharma : Publication of new data on NTCD-M3	22-07-26	PU
Destiny Pharma receives award from the Cystic Fibrosis Foundation	22-07-13	AQ
Destiny Pharma announce publication of XF-73 drug synergy data	22-07-07	AQ
Destiny Pharma announces start of a new XF-73 research programme	22-07-06	AQ
Destiny Pharma : Board Changes	22-05-26	PU
Destiny Pharma : 27 April 2022 – Posting of Annual Report and Notice of AGM	22-04-27	PU

No results for this search